New cell culture microbioreactor system improves clone selection
SSB's new generation of ambr 15 supports cell and gene therapy applications, including HEK293 for viral vector production, T-cells, iPSCs and other immune-derived cell lines.
Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry, is introducing its new generation of ambr 15 cell culture automated microbioreactor system. The Generation 2 is the successor to the well-established ambr 15 cell culture system, proven in the industry to significantly reduce cell line development timelines and increase lab productivity. The new system offers increased flexibility and expanded capability for clone selection, media and feed optimization and early process development work.
The ambr 15 cell culture Generation 2, based on SSB’s gold-standard ambr technology, replicates laboratory-scale bioreactor performance at the microscale (10-15 mL) and controls up to 48 single-use bioreactor cultures in parallel. Its new design incorporates novel features to provide greater process flexibility, expands the system’s functionality and allows more applications to be investigated. In addition, a new ambr clone selection software, included as a one-year license, provides simplified, streamlined multivariate data analysis for faster, more consistent cell line screening and ranking.
Selection of clones, media and feeds can be performed under perfusion mimic conditions using new functionality to bleed large volumes of culture and quickly remove spent media from the ambr 15 microbioreactors. A new flexible workstation layout and an expanded tip bin capacity provide greater operator walk-away time.
Adaptation of cell lines to different media for media screening studies can be performed in ambr 15 microbioreactors using new culture passage steps and rapid vessel drain functionality. New media mixing steps automate the creation of media blends, eliminating the need to pre-mix, saving time and reducing chance of error. Clone stability studies can also be set up with serial passages performed and fully automated in the microbioreactors.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance